Metastasizing, Luciferase Transduced MAT‑Lu Rat Prostate Cancer Models: Follow up of Bolus and Metronomic Therapy with Doxorubicin as Model Drug

Metastasizing, Luciferase Transduced MAT‑Lu Rat Prostate Cancer Models: Follow up of Bolus and Metronomic Therapy with Doxorubicin as Model Drug

The most fatal outcomes of prostate carcinoma (PCa) result from hormone-refractory variants of the tumor, especially from metastatic spread rather than from primary tumor burden. The goal of the study was to establish and apply rat MAT-Lu prostate cancer tumor models for improved non-invasive live f...

Full description

Bibliographic Details
Main Authors: Peter Woias, Vittorio Ziroli, Frank Goldschmidtboing, Ulrich Massing, Norbert Esser, Andreas Geipel, Peter Jantscheff
Format: Article
Language:English
Published: MDPI AG 2011-06-01
Series:Cancers
Subjects:
prostate cancer
MAT-Lu
orthotopic
bioluminescence
luciferase
rat
dunning
Online Access:http://www.mdpi.com/2072-6694/3/2/2679/

Internet

http://www.mdpi.com/2072-6694/3/2/2679/

Similar Items